In conclusion, the present suggest that after S. 4,[5],12:i:- infection, LGG administration enables reprogramming of microbe–microbe interactions and alters ileal microbiota with associated specific CD3-CD19- cell subset homeostasis (Figure 7). The gene discussed is CD19; the disease is infection.